The Endocrinology Network® Diabetes clinical resource center offers readers the very latest news and information related to diabetes management. Including content related to type 1 diabetes, type 2 diabetes, and gestational diabetes, the diabetes clinical resource center hosts information on FDA approvals, the latest studies, and practice updates for clinicians practicing in the field of endocrinology.

Race, Gender, & Income Influence Access to SGLT2 Inhibitors Among US Patients

April 15, 2021

Using data from nearly 1 million patients with type 2 diabetes in a commercial database, investigators provide a comprehensive of the impact race/ethnicity, gender, and income can have on the likelihood of receiving a prescription for SGLT2 inhibitors.

Low-Intensity Walking Program Fails to Show Benefit for Peripheral Artery Disease

April 14, 2021

A trial led by clinicians from Northwestern Medicine suggests the presence of ischemic leg symptoms could serve as a useful indicator for patients to help determine whether they will see a meaningful benefit from their walking program.

Patients with Coronary Syndromes 3 Times More Likely to have Diabetes, More Susceptible to Adverse Outcomes

April 07, 2021

An analysis of the CLARIFY registry suggests patients with chronic coronary syndromes were 3 times more likely than the general population to have diabetes and these patients were at a greater risk of multiple adverse outcomes compared to their counterparts without diabetes.

High-Frequency Spinal Cord Stimulation Could Offer Hope in Refractory Diabetic Neuropathy

April 06, 2021

Results of a randomized clinical trial suggest treatment with high-frequency spinal cord stimulation added to conventional medical management could lead to pain relief and improvements in quality of life among patients with refractory peripheral diabetic neuropathy.

NYHA Class Less Sensitive than KCCQ-OS for Capturing Heart Failure Progression

March 30, 2021

An analysis of the CHAMP-HF registry indicates KCCQ-OS was more sensitive at tracking changes in disease state among heart failure patients, indicating the importance of including patient-reported outcome measures in heart failure management.